Search Results for: CAR-T Cells
Funding Cell and Gene Therapy
Big Pharma-Backed Capstan Launches With $165 Million To Combine Cell Therapy And mRNA Technology
2022-09-15
Ranking & Reports Synthetic Biologics
2026: The Promise of Synthetic Biology
2022-08-11
Partnerships Roche
Roche Dives Deeper into Off-The-Shelf Cell Therapies in Poseida Partnership
2022-08-04
Special Gene and Cell Therapy
Gene & Cell Therapy’s Big Leaps in the Past 5 Years
2022-07-08
Trials & Approvals Roche
Roche’s Non-Hodgkin Lymphoma Drug Could See Accelerated Approval By December
2022-07-07
M&A T-cellB-cell Lymphoma
AstraZeneca Buys TeneoTwo in $1.2 Billion T-Cell Engager Play
2022-07-06
Special Bristol Myers Squibb
Bristol Myers Squibb Requests $1.2 Billion Patent Revival From Supreme Court
2022-06-17
Funding Series A Funding
Series A Funding Successfully Wraps Up for Two Up-and-Coming Biotechs
2022-06-10
Trials & Approvals Follicular Lymphoma
Europe Okays Roche’s CAR-T Competitor for Blood Cancer
2022-06-09
R&D DNA
Antitumor Response of Left-handed Z-DNA Reinvigorates Immunotherapy’s Efficacy
2022-06-02
Trials & Approvals CAR T-cell Therapy
Novartis CAR-T Cell Therapy Receives FDA Approval for Third Indication to Treat Follicular Lymphoma
2022-05-30
PRNewswire
Embracing Win-win Cooperation – ASEAN Consul Generals, officials and representatives of chambers of commerce in Guangzhou visited Biosyngen
2022-05-27
Trials & Approvals Johnson & Johnson
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Special ASGCTJapan
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
Technology CAR T-cell Therapy
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
1 2 3 4 5 … 10
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top